Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
China flag China · Delayed Price · Currency is CNY
4.260
-0.100 (-2.29%)
May 21, 2026, 3:00 PM CST

SHA:603669 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
142.02155.51254.09343.42575.76986.94
Trading Asset Securities
14.8113.3231.22390.59389.51579.13
Cash & Short-Term Investments
156.84168.83285.31734.01965.281,566
Cash Growth
-42.05%-40.83%-61.13%-23.96%-38.36%-10.36%
Accounts Receivable
283.01256.22243.265.692.21124.89
Other Receivables
2.452.44.692.183.537.71
Receivables
285.46258.61247.8967.7895.74132.61
Inventory
77.2784.0327.8856.7749.1451.67
Other Current Assets
22.4113.925.5322.9721.8937.95
Total Current Assets
541.98525.38586.61881.531,1321,788
Property, Plant & Equipment
402.87405.17469.67505.35496.32484.53
Long-Term Investments
64.3364.4675.67100.8777.866.67
Goodwill
-----2.03
Other Intangible Assets
93.1893.61100.9108.44115.79124.1
Long-Term Deferred Tax Assets
---2.20.216.83
Long-Term Deferred Charges
10.7411.4214.2317.1520.123.92
Other Long-Term Assets
8.586.738.259.0213.2218
Total Assets
1,1221,1071,2551,6251,8552,514
Accounts Payable
140.16129.1289.1385.549.2648.53
Accrued Expenses
2.085.9922.0611.9514.625.25
Short-Term Debt
15.0115.01-117.41205.24460.29
Current Portion of Long-Term Debt
281.86274.540.420.38-85.06
Current Portion of Leases
--1.772.641.143.19
Current Income Taxes Payable
8.166.670.030.310.021.28
Current Unearned Revenue
11.4511.436.8810.488.846.61
Other Current Liabilities
13.8635.8299.0314.4423.3318.64
Total Current Liabilities
472.57478.58219.31243.11302.42648.85
Long-Term Debt
18-257.99439.34412.52385.91
Long-Term Leases
2.132.134.075.841.0714.77
Long-Term Unearned Revenue
4.414.472.412.84.095.81
Long-Term Deferred Tax Liabilities
1.321.321.782.420.740.19
Total Liabilities
498.43486.5485.57693.52720.841,056
Common Stock
721.25721.25721.24721.24721.24721.23
Additional Paid-In Capital
304.4304.4262.65255.64255.63255.54
Retained Earnings
-352.61-355.56-162.32-31.56119.94387.95
Treasury Stock
-110.02-110.02-110.02-108.37-56.26-
Comprehensive Income & Other
60.2160.2158.2194.0994.0994.11
Shareholders' Equity
623.24620.28769.76931.041,1351,459
Total Liabilities & Equity
1,1221,1071,2551,6251,8552,514
Total Debt
317291.68264.26565.61619.97949.22
Net Cash (Debt)
-160.16-122.8521.05168.4345.3616.84
Net Cash Growth
---87.50%-51.23%-44.02%-28.25%
Net Cash Per Share
-0.22-0.170.030.230.480.86
Filing Date Shares Outstanding
720.95697.34703.54703.83721.24721.23
Total Common Shares Outstanding
720.95697.34703.54703.83721.24721.23
Working Capital
69.446.8367.3638.42829.621,139
Book Value Per Share
0.860.891.091.321.572.02
Tangible Book Value
530.06526.67668.86822.611,0191,333
Tangible Book Value Per Share
0.740.760.951.171.411.85
Buildings
--374.09378.47369.78316.92
Machinery
--162.03187.09191.33197.49
Construction In Progress
--228.22220.06190.18187.96
Source: S&P Global Market Intelligence. Standard template. Financial Sources.